8 October 2024 Block 1 Seminars
Opening Remarks
What’s Happening with AI: Current Reality & Future Opportunities
• Integrating AI within the early stages to accelerate and optimize clinical trial design
• Exploring how AI technology can be implemented within minor areas to enhance overall clinical outcomes
• Analyzing technical skills and knowledge gaps to enhance training and ensure proper use of tools and data
• Will AI replace people or train people?
Speaker
Andrew LeBlanc Associate Director, Digital Health - Alexion Pharmaceuticals
Understanding Global Feasibility and Analytics for Enhanced Decision-Making
- Finding the Right Places: Figuring out the right countries and sites to conduct your clinical trial
- Understanding Local Factors: Considering patient population, healthcare infrastructure, and regulatory environment in different countries
- Leveraging real world data to support recruitment of diverse populations
- Enhanced analytics for decision making: role of predictive modelling, and new AI technologies
Speaker
Stephanie Vakaljan Director, Clinical Operations Planning - GSK
Empowering Patient-Centric Outcomes: The Synergy of ePRO, Wearables, and Patient Engagement in Clinical Trials
- Implementing tailored strategies to foster active participation and feedback from patients throughout the trial duration
- Automating Collection of Patient Outcomes: Ensuring the integrity and reliability of collected data through quality control measures and leveraging advanced analytics
- Adhering to regulatory standards and Integrating ePRO and wearable data streams to gain a comprehensive understanding of patient experiences, behaviors, and health outcomes.
- Future-Proofing Research Methodologies: Adapting to emerging technologies to continuously enhance patient-centricity
Speaker
Wessam Sonbol Founder, CEO - Delve Health

Technology Demonstrations with Evidation and Mushroom Solutions
This session provides an additional opportunity to meet with our product and solution providers in the exhibition hall to learn more about the products, technology,
and services that have been developed to solve some of your unique challenges. The technology demonstrations will last approximately 8 minutes on four cycles
with the opportunity to ask questions immediately afterwards over the refreshment break.
Networking Break & Exhibition
Implementing Technology for Remote Consent to Enhance Participant Engagement
- Effective informed consent management for standardized and ethical clinical trials
- Reducing participant burden through digital accessibility, real-time support, and easy-to-use applications
- Assessing Site Readiness: Ensuring that platform aligns with the needs & preferences of trial sites and participants
- Optimizing consent documentation & ensuring compliance with regulatory standards
Are Decentralized Clinical Trials Even Good? Evaluating the Reality of DCTs and Reasons Why People Are Avoiding this Term
Speaker
Jen Yip Associate Director, Digital Trials & Patient Engagement - Novartis
Driving Clinical Trial Diversity and Equity through Digital Accessibil- ity Standards, Ensuring Inclusive Participation for Individuals with Disabilities
Exploring the Transformative Impact of Clinical Trials Operations Automation (CTOps): Enhancing Clinical Trials Through Advanced Automation
Speaker
Srinivas Kommalapati CEO - Mushroom Solutions
Utilizing Participant Feedback to Transform Decentralized Clinical Trials: eConsent, Telemedicine, Home Nursing & Transportation Services
Speaker
Lani Hashimoto Associate Director, Patient Engagement - Novartis